| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $0-100.0% | $266+5220.0% | $5-99.5% | $993-67.3% | $3K |
| Total Revenue | $0-100.0% | $266+5220.0% | $5-99.5% | $993-67.3% | $3K |
| Professional fees | $1.3M+1089.6% | $110K+25.1% | $88K-27.2% | $121K+86.2% | $65K |
| Salaries | $1.1M+1206.5% | $81K+50.0% | $54K | $0 | — |
| Depreciation and amortization | $281K+378.9% | $59K | — | — | — |
| Bad debt expense | $0-100.0% | $30K | — | — | — |
| Impairment of goodwill and intangible assets | $2.9M+1382.5% | $198K | — | — | — |
| Other general and administrative costs | $1.1M+1676.5% | $59K-65.5% | $172K-10.0% | $191K+78.1% | $107K |
| Total operating expenses | $6.6M+1136.1% | $537K+71.0% | $314K+0.7% | $312K+81.2% | $172K |
| Loss from operations | -$6.6M-1136.7% | -$537K-70.9% | -$314K-1.0% | -$311K-83.8% | -$169K |
| Other income | $0-100.0% | $5K+1614.5% | $317+207.8% | $103+0.0% | $103 |
| Interest and other expense | -$817K-431.5% | -$154K-348.1% | -$34K | $0 | — |
| Financing cost | -$181K | $0 | — | — | — |
| Change in fair value of derivative financial instruments | -$150K | $0 | — | — | — |
| Loss on conversion of shares | $0+100.0% | -$426K | $0 | — | — |
| Loss on exercise of warrants | $0+100.0% | -$60K | $0 | — | — |
| Other expense net | -$1.1M-80.9% | -$634K-1766.3% | -$34K | — | — |
| Net loss before income tax | -$7.8M-565.1% | -$1.2M-236.3% | -$348K-11.9% | -$311K-83.8% | -$169K |
| Provision for income taxes (benefit) | $0 | $0 | $0 | $0 | $0 |
| Net Loss | -$7.8M-565.1% | -$1.2M-236.3% | -$348K-11.9% | -$311K-83.8% | -$169K |
| Net Loss Per Common Stock - basic and fully diluted | -$0.23-360.0% | -$0.05-400.0% | -$0.01 | — | — |
| Stock outstanding - basic and fully diluted | $33.7M+34.2% | $25.1M+6.2% | $23.6M | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.